Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets

Yang Zhou; Philippe Patrick Monnier; Jin-Zhou Feng; Shou-Gang Guo; Cong-Cong Wang

doi:10.3389/fneur.2024.1427299

Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets

Front Neurol. 2024 May 17:15:1427299. doi: 10.3389/fneur.2024.1427299. eCollection 2024.

Authors

Yang Zhou¹, Philippe Patrick Monnier², Jin-Zhou Feng³, Shou-Gang Guo⁴, Cong-Cong Wang^{1

5}

Affiliations

¹ Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, China.
² Department of Physiology, University of Toronto, Toronto, ON, Canada.
³ Department of Neurology, The First Affliated Hospital of Chongqing Medical University, Chongqing, China.
⁴ Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.
⁵ Shandong Institute of Neuroimmunology, Jinan, China.

No abstract available

Keywords: MOGAD; MS; NMOSD; biomarkers; molecular mechanisms; therapeutic.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (82371356) and the China Postdoctoral Science Foundation (2023M732135).